Endoscopes Market Report Scope & Overview:

The Endoscopes Market was valued at USD 18.10 Billion in 2025 and is expected to reach USD 41.09 Billion by 2035, growing at a CAGR of 8.54% from 2026 to 2035.

Endoscopy refers to a flexible or rigid tube fitted with a light source and a camera on one end, which makes it possible for health professionals to examine conditions inside various organs and cavities without conducting any major surgical procedures. Endoscopes are widely used for diagnosis and treatment procedures due to increase in demand for minimally invasive surgery where physicians can view inside the body without conducting any major surgeries. The use of endoscopes is common in various diagnoses of many diseases, which include inflammatory bowel disease, stomach cancer, colon cancer, respiratory infections, and respiratory cancer, among others. The private and government support programs and increasing demand of patients and physicians for endoscopy procedures continue to contribute to market growth.

Fujifilm gained 510(k) clearance from the United States Food and Drug Administration in March 2024 for its novel AI detection system, CAD EYE, for endoscopic imaging, enabling endoscopists to offer real-time detection and removal of colonic mucosal lesions such as polyps and adenomas irrespective of their size, shape, and color.

To Get More Information On Endoscopes Market - Request Free Sample Report

Endoscopes Market Trends

• Endoscopy and related devices have gained immense traction in recent years across both diagnostic and therapeutic applications.
• Increasing frequency of chronic diseases combined with an augmenting elderly population continues driving sustained demand.
• Great acceptance rate of technically cutting-edge endoscopy devices continues supporting physician adoption of advanced imaging technology.
• Rising demand for single-use endoscopes to eliminate the risk of device-related infections continues reshaping product preferences.
• Increasing number of product releases and growing popularity of flexible endoscopes continue supporting sustained category growth.

The United States Endoscopes Market Outlook

The United States Endoscopes Market was valued at USD 5.19 Billion in 2025 and is expected to reach USD 12.09 Billion by 2035, growing at a CAGR of 8.82% from 2026 to 2035.

The United States market continues to benefit from an upsurge in frequency of chronic diseases plus an augmenting elderly population, alongside great acceptance of technically cutting-edge endoscopy devices and strong physician responsiveness to new technology. Hospitals were the dominating end-user in 2025 due to the wide adoption of endoscopes and the rising number of surgeries performed in hospitals, while continuous private and government subsidies have supported consistent demand within the biggest healthcare providers across the country.

Boston Scientific continued expanding its endoscopy product portfolio in 2025, reinforcing its position among the leading American medical device manufacturers serving hospitals and ambulatory surgical centers requiring advanced diagnostic and therapeutic endoscopic technology.

Endoscopes Market Segmentation Analysis

• By Product, the Flexible Endoscopes segment held approximately 47.00% share in the Endoscopes Market in 2025, while the Disposable Endoscopes segment is the fastest growing, with a CAGR of approximately 19.30%.
• By Application, the GI Endoscopy segment held approximately 51.00% share in the Endoscopes Market in 2025, while the Urology segment is the fastest growing.
• By End-User, the Hospitals segment held approximately 48.10% share in the Endoscopes Market in 2025, while the Ambulatory Surgical Centers segment is the fastest growing.

By Product, Flexible Endoscopes Segment Dominated the Endoscopes Market, while disposable endoscopes grows fastest

The Flexible Endoscopes segment held approximately 47.00% of total market revenue in 2025, favored for its transparent, bendable fibers and optical technology that transfers light and returns images to the viewer with genuine clinical advantages over rigid alternatives. Because of these benefits, the increasing number of product releases, and the growing popularity of flexible endoscopes among physicians, that established clinical preference continues to keep this product segment firmly at the top of the broader product segmentation, with rigid, capsule, and robot-assisted endoscopes continuing to represent substantial additional product categories.

The Disposable Endoscopes segment is projected to grow at the fastest CAGR of approximately 19.30% during the forecast period, driven by rising demand for single-use endoscopes to eliminate the risk of device-related infections that reprocessed reusable endoscopes can carry. Rising adoption of these infection-control-focused devices, supported by cost-effectiveness and ongoing investments and innovations by industry players, continues pushing this product category's growth rate ahead of the broader product segmentation.

By Application, GI Endoscopy Segment Dominated the Endoscopes Market, while Urology grows fastest

The GI Endoscopy segment held approximately 51.00% of total market revenue in 2025, anchored by extensive diagnostic and therapeutic use for chronic gastrointestinal disorders including inflammatory bowel disease, stomach cancer, and colon cancer. That established, high-volume clinical application continues to keep GI endoscopy firmly at the top of the broader application segmentation across nearly every major regional healthcare market worldwide.

The Urology segment is projected to grow at the fastest CAGR during the forecast period, supported by rising diagnosis rates for urological conditions and expanding minimally invasive urological procedure adoption. Rising clinical demand for urological endoscopic diagnosis and treatment continues pushing this application category's growth rate ahead of the broader application segmentation.

By End-User, Hospitals Segment Dominated the Endoscopes Market, while Ambulatory Surgical Centers grows fastest

The Hospitals segment held approximately 48.10% of total market revenue in 2025, driven by extensive implementation of endoscopes and an upturn in the amount of surgeries accomplished in hospital-based environments. Cumulative private and government subsidy programs and an upward trend among patients and physicians to execute endoscopic processes in hospital-based settings continue keeping hospitals firmly at the top of the broader end-user segmentation.

The Ambulatory Surgical Centers segment is projected to grow at the fastest CAGR during the forecast period, as the broader shift toward outpatient procedures continues driving endoscopic diagnostic and therapeutic volume away from traditional hospital settings. Rising patient and payer preference for lower-cost, outpatient endoscopic procedures continues pushing this end-user category's growth rate ahead of the broader end-user segmentation.

Regional Analysis

North America Endoscopes Market Insights

North America led the global Endoscopes Market with the highest market share of approximately 41.00% in 2025, driven by an upsurge in frequency of chronic diseases plus an augmenting elderly population, and great acceptance of technically cutting-edge endoscopy devices. Strong physician responsiveness to new technology continued reinforcing this leadership position throughout the year.

The United States accounted for roughly 84.90% of regional revenue, reflecting its concentration of leading endoscope manufacturers and comprehensive hospital-based healthcare infrastructure. Canada contributed a smaller but steadily growing share of regional revenue, supported by its own expanding endoscopic procedure adoption, keeping North America firmly ahead of every other region in this market.

Get Customized Report as Per Your Business Requirement - Enquiry Now

Europe Endoscopes Market Insights

Europe held a substantial share of the global Endoscopes Market in 2025, supported by well-established national health insurance coverage and strong medical device manufacturing infrastructure across the continent. Germany accounted for roughly 27.20% of regional revenue, supported by its concentration of endoscope manufacturers and comprehensive healthcare infrastructure.

France, the United Kingdom, and Italy followed a broadly similar trajectory, as continued investment in minimally invasive procedure adoption extended endoscopes demand across the continent's largest healthcare markets. Continued regulatory support for infection-control-focused disposable endoscope adoption is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Endoscopes Market Insights

Asia Pacific was the fastest-growing region in the global Endoscopes Market, supported by expanding healthcare infrastructure investment, rising chronic disease prevalence, and growing endoscopic procedure adoption across the region's largest and most populous economies. Rising healthcare access continued driving regional demand at a pace considerably faster than more mature Western markets.

Japan accounted for roughly 36.40% of regional revenue, supported by its concentration of leading endoscope manufacturers and advanced healthcare technology adoption. China and South Korea contributed significant additional regional demand through their own expanding healthcare infrastructure investment, reinforcing Asia Pacific's position as the clear growth leader in this market.

MEA & Latin America Endoscopes Market Insights

The Middle East and Africa region recorded steady growth in endoscopes adoption in 2025, driven by expanding healthcare infrastructure investment and growing government support for minimally invasive procedure access across the Gulf states in particular. The UAE accounted for roughly 26.30% of regional revenue, supported by national healthcare modernization strategies and rising demand for advanced endoscopic technology.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.10% of regional revenue, where growing healthcare infrastructure investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional endoscopic procedure adoption expanded further through the remainder of the forecast period.

Growth Drivers: Minimally Invasive Surgery Demand and Chronic Disease Prevalence

Rising demand for minimally invasive surgery continues to be the central force behind endoscopes market growth, as endoscopes allow physicians to observe the inside of the body without performing major surgery. Increasing frequency of chronic diseases and an augmenting elderly population continue reinforcing structural demand growth across nearly every major regional healthcare market worldwide.

Great acceptance rate of technically cutting-edge endoscopy devices and great responsiveness among patients and physicians continue reinforcing sustained market expansion. Cumulative private and government subsidy programs continue supporting broader access to endoscopic diagnostic and therapeutic procedures, reinforcing sustained market growth through the forecast period.

Restraints: Reprocessing Infection Risk and High Equipment Costs

Persistent concerns regarding device-related infections associated with reprocessed reusable endoscopes continue driving genuine clinical and regulatory scrutiny of traditional endoscope sterilization protocols. That infection risk concern continues reinforcing demand for disposable alternatives while simultaneously requiring sustained investment in reprocessing quality assurance for reusable device fleets.

The substantial capital investment required for advanced, technologically sophisticated endoscope systems continues restricting adoption among smaller healthcare facilities working with constrained capital budgets. That cost barrier continues concentrating the most advanced endoscopic technology among larger hospital systems and well-resourced ambulatory surgical centers.

Opportunities: AI-Assisted Diagnostic Integration and Disposable Technology Expansion

Further development of AI-assisted diagnosis in endoscopy provides significant potential for companies that can cater to doctors who are looking to increase the accuracy and certainty of their diagnoses. Companies that can produce clinically approved and regulated AI systems will be able to benefit from this developing technology.

Continued expansion of disposable endoscope technology presents a further significant growth avenue, as rising demand for single-use devices to eliminate infection risk continues driving investment and innovation among industry players. Manufacturers capable of delivering cost-effective, high-performance disposable endoscopes stand to capture meaningful new revenue streams through 2035.

Recent Developments:

• 2025: Olympus continued expanding its endoscopy imaging technology portfolio, strengthening its position among the leading global manufacturers serving hospitals requiring advanced flexible and disposable endoscope systems.
• 2025: Ambu continued advancing its single-use endoscope product line, targeting healthcare providers seeking infection-control-focused disposable devices across gastrointestinal and pulmonology applications.
• 2025: Karl Storz continued developing its rigid and flexible endoscopy technology, strengthening its position serving hospitals and ambulatory surgical centers requiring precision diagnostic and surgical visualization equipment.

Endoscopes Market key players are:

• Olympus Corporation
• Fujifilm Holdings Corporation
• Karl Storz SE & Co. KG
• Stryker Corporation
• Boston Scientific Corporation
• Medtronic plc
• Richard Wolf GmbH
• PENTAX Medical
• CONMED Corporation
• Smith & Nephew plc
• Ambu A/S
• Intuitive Surgical, Inc.
• Cook Medical Incorporated
• Arthrex, Inc.
• B. Braun Melsungen AG
• HOYA Corporation
• Steris plc
• Verathon Inc.
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.

Endoscopes Market Report Scope :